- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Balaxi Pharmaceuticals Limited has announced a board meeting concerning the compliance with Regulation 74(5) of SEBI regulations for the quarter ended December 31, 2024. Aarthi Consultants, the Registrar and Share Transfer Agent, confirmed the company's adherence to the necessary actions for dematerialization of securities during the specified period. This indicates a structured approach to managing the company's securities, potentially enhancing operational efficiency. For investors, this update may imply a positive outlook, reflecting the company’s commitment to maintaining transparent compliance and governance practices, which could bolster investor confidence.